Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
October 15, 2025 17:15 ET | Source: Annovis Bio Inc. MALVERN, Pa.,…
C1 Fund Inc. Announces Equity Purchase in Ripple, Leading Enterprise Blockchain Solutions Provider
PALO ALTO, Calif.--(BUSINESS WIRE)--C1 Fund Inc. (NYSE: CFND) (“C1 Fund” or the…
PureTech Health plc Half-Year Report
Achieved meaningful progress toward key value inflection points across our diversified portfolio,…
XORTX Completes USD $114,500 Private Placement
August 08, 2025 19:54 ET | Source: XORTX Therapeutics Inc. NOT FOR…
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds…
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 04, 2025 15:10 ET | Source: Spectral Medical Inc. TORONTO, July…
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
June 18, 2025 16:30 ET | Source: Cellectar Biosciences, Inc. FLORHAM PARK,…
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…